Corbus Pharmaceuticals Holdings, Inc. - Common Stock, $0.0001 par value (CRBP)

CUSIP: 21833P301

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / Common Stock, $0.0001 par value
Shares outstanding
17,685,185
Total 13F shares
10,952,105
Share change
-685,356
Total reported value
$129,272,235
Put/Call ratio
12%
Price per share
$11.80
Number of holders
98
Value change
-$16,308,014
Number of buys
45
Number of sells
47

Quarterly Holders Quick Answers

What is CUSIP 21833P301?
CUSIP 21833P301 identifies CRBP - Corbus Pharmaceuticals Holdings, Inc. - Common Stock, $0.0001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Corbus Pharmaceuticals Holdings, Inc. - Common Stock, $0.0001 par value (CRBP) as of Q4 2024

As of 31 Dec 2024, Corbus Pharmaceuticals Holdings, Inc. - Common Stock, $0.0001 par value (CRBP) was held by 98 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 10,952,105 shares. The largest 10 holders included Cormorant Asset Management, LP, ORBIMED ADVISORS LLC, Octagon Capital Advisors LP, BlackRock, Inc., VANGUARD GROUP INC, ADAGE CAPITAL PARTNERS GP, L.L.C., MILLENNIUM MANAGEMENT LLC, Altium Capital Management LLC, Prosight Management, LP, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 98 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.